Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SmokeBreak is a digital health company focused on providing innovative solutions for smoking cessation and nicotine dependence. The company offers a mobile-based digital therapeutic platform designed to help users quit smoking through behavioral modification, personalized coaching, and data-driven insights. By leveraging behavioral science and mobile technology, SmokeBreak aims to improve the success rates of individuals attempting to overcome tobacco addiction. The platform is primarily marketed to employers and health plans as a wellness benefit to reduce healthcare costs associated with smoking-related illnesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smoke-Break.